Rheo-Erythrocrine Dysfunction as a Biomarker for RIC Treatment in Acute Ischemic Stroke
type: MedicalStudy
description: Rheo-Erythrocrine Dysfunction as a Biomarker for RIC Treatment in Acute Ischemic Stroke - Pilot, Single-center, Randomized, Patient-assessor Blinded, Sham-controlled Study
status: COMPLETED
study design: INTERVENTIONAL
phase: NA
start date: 2020-07-29
end date: 2021-07-31
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT04266639
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Grethe Andersen
study subject: Stroke, Acute
study subject: Ischemic Stroke
study subject: Cerebrovascular Disorders
study subject: Central Nervous System Diseases
keywords: NA
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Stroke, Acute
keywords: Ischemic Stroke
keywords: Cerebrovascular Disorders
keywords: Central Nervous System Diseases

AI Analytics
type: Organization